Porth's Essentials of Pathophysiology, 4e

373

Disorders of the Immune Response

C h a p t e r 1 6

A. Why did the provider do an HIV test after the man was diagnosed with PCP? B. Is there a way to prevent PCP? C. What classification does this man fall into based on his CD4 + count and symptomatology, and why? R E F E R E N C E S 1. Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology . 7th ed. Philadelphia, PA: Elsevier Saunders; 2012:319–344, 365–388, 407–424, 445–470. 2. Kumar V, Abbas AK, Fautso N, et al. Robbins and Cotran Pathologic Basis of Disease . 8th ed. Philadelphia, PA: Saunders Elsevier; 2010:183–249. 3. Warren JS, Strayer DS. Immunopathology. In: Rubin R, Strayer DS, eds. Rubin’s Pathology: Clinicopathologic Foundations of Medicine . 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2012:115–156. 4. Kay AB. Allergy and allergic disease (parts 1 and 2). N Engl J Med. 2001;344:(1,2)30–37, 109–113. 5. Galli SJ. New concepts about the mast cell. N Engl J Med. 1993;328:257–265. 6. Arnold JJ, Williams PAM. Anaphylaxsis: recognition and management. Am Fam Physician. 2011;84(10):1111–1118. 7. Lieberman P. Anaphylaxis. Med Clin North Am. 2006;90:77–95. 8. Lieberman P, Kemp SF, Oppenheimer J, et al.; Chief Editors for the Joint Task Force on Practice Parameters, Joint Counsel of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115(3 suppl):S483–S523. 9. Mucci T, Govindaraj S, Tversky J. Allergic rhinitis. Mt Sinai J Med. 2011;78(5):634–644. 10. Steinsvaag SK. Allergic rhinitis: an updated overview. Curr Allergy Asthma Rep. 2012;12:99–103. 11. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol. 2010;125:S116–S125. 12. Masilamani M, Commins S, Shreffler W. Determinants of food allergy. Immunol Allergy Clin North Am. 2012;33:11–33. 13. Sampson HA. Peanut allergy. N Engl J Med. 2002;346:1294–1299. 14. Berke RC, Singh A, Guralnice M. Atopic dermatitis: an overview. Am Fam Physician. 2012;86:35–42. 15. Mark BJ, Slavin RG. Allergic contact dermatitis. Med Clin North Am. 2006;90:169–185. 16. Ohshimo S, Bonella F, Guzman J, et al. Hypersensitivity pneumonitis. Immunol Allergy Clin North Am. 2012;32:537–556. 17. Gilliam AC. Update on graft versus host disease. J Invest Dermatol. 2004;123:251–257. 18. Choi SW, Levine JE, Ferrara JLM. Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am. 2010;30:75–101. 19. Crawford JM. The liver and biliary tract. In: Kumar V, Abbas AK, Fausto N, eds. Robbins and Cotran Pathologic Basis of Disease . 7th ed. Philadelphia, PA: Elsevier Saunders; 2005:919–920. 20. Yin Y, Yili L, Maniuzza RA. Structural basis for self-recognition by autoimmune T-cell receptors. Immunol Rev. 2012;250(1):32–48. 21. Davidson A, Diamond B. Autoimmune disease. N Engl J Med. 2001;345:340–350. 22. Rioux JD, Abbas AK. Paths to understanding the genetic basis of autoimmune disease. Nature. 2005;435:584–589. 23. Goodnow CC, Sprent J, de St Groth BF, et al. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature. 2005;435:590–597. 24. Navratil JS, Sabatine JM, Ahearn JM. Apoptosis and immune responses to self. Rheum Dis Clin North Am. 2004;30:193–212. 25. Jiang H, Chess L. Regulation of immune responses by T cells. N Engl J Med. 2006;354:166–176.

26. Kronberg M, Rudensky A. Regulation of immunity by self- reactive T cells. Nature. 2005;435:598–604. 27. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev. 2007;6:366–372. 28. Cutolo M, Sulli A, Seriolo S, et al. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol. 1995;13:217–226. 29. Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol. 2012;42:102–111. 30. Anders H-J, Zecher D, Pawar RD, et al. Molecular mechanisms of autoimmunity triggered by microbial infection. Arthritis Res Ther. 2005;7:215–224. 31. Llewelyn M, Cohen J. Superantigen antagonist peptides. Crit Care. 2001;5:53–55. 32. Verbsky JW, Grossman WJ. Cellular and genetic basis of primary immune deficiencies. Pediatr Clin North Am. 2006;53:649–684. 33. Bonilla FA, Geha RS. Update on primary immunodeficiency diseases. J Allergy Clin Immunol. 2006;117(2 suppl):S435–S441. 34. Parvaneh N, Casanova J-L, Notarangelo LD. Primary immunodeficiencies: a rapidly evolving story. J Allergy Clin Immunol. 2013;131:314–323. 35. Buckley R. Evaluation of suspected immunodeficiency. In: Kliegman RM, Stanton BF, St Gemelli JW, et al. Nelson Textbook of Pediatrics . 19th ed. Piladelphia, PA: Elsevier Saunders, 2011:714–722.e1. 36. The Jeffrey Modell Foundation Medical Advisory Board. Ten Warning Signs of Primary Immunodeficiency . 2009. Available at: http://www.info4pi.org/aboutPI/index.cfm?section=aboutPI&con tent=warningsigns. Accessed August 26, 2013. 37. Sorensen RU, Moore C. Antibody deficiency syndromes. Pediatr Clin North Am. 2000;47:1225–1252. 38. Rose ME, Lang DM. Evaluating and managing hypogammaglobulinemia. Cleve Clin J Med. 2006;73:133–144. 39. Elder ME. T-cell immunodeficiencies. Pediatr Clin North Am. 2000;47:1253–1274. 40. Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol. 2004;22:625–655. 41. Rudd CE. Disabled receptor signaling and new primary immunodeficiency disorders. N Engl J Med. 2006;354:1874–1877. 42. Buckley RH. The long quest for neonatal screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2012;129(3):597–604. 43. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2006;117:725–738. 44. UNAIDS. 2012 UNAIDS Report on the Global AIDS Epidemic, November 2012 . Available at: http://www.unaids.org/en/resources/ publications/2012/name,76121,en.asp. Accessed August 26, 2013. 45. Karim SSA, Karim QA, Gouws E, et al. Global epidemiology of HIV-AIDS. Infect Dis Clin North Am. 2007;21:1–17. 46. Zetola NM, Pilcher CD. Diagnosis and management of acute HIV infection. Infect Dis Clin North Am. 2007;21:19–48. 47. UNAIDS. 2008 Report on Global AIDS Epidemic, August 2008 . Available at: http://www.unaids.org/en/KnowledgeCentre/ HIVData/GlobalReport/2008/2008_Global_report.asp. Accessed August 26, 2013. 48. Gershon RRM, Vlahov D, Nelson KE. The risk of transmission of HIV-1 through non-percutaneous, non-sexual modes: a review. AIDS. 1990;4:645–650. 49. Public Health Agency of Canada. Summary: Estimation of HIV prevalence and incidence in Canada, 2011 . 2012. Available at: http://www.phac-aspc.gc.ca/aids-sida/publication/ survreport/2011/dec/index-eng.php. Accessed August 26, 2013. 50. Centers for Disease Control and Prevention. Estimated HIV incidence in the United States, 2007–2010. HIV Surveillance

Supplemental Report. December 2012;17(4). Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/ reports/#supplemental. Accessed August 26, 2013.